(particularly rubella). 1, 20, 21 The clinical presentations for this rare disease are similar based on case reports; however, it is not known whether the phenotype, extent of aortic involvement, or response to medical and surgical management may differ by potential etiology.
Children with MAS typically present with severe arterial hypertension, which can lead to serious complications such as coronary artery disease, congestive heart failure, left ventricular hypertrophy, and cerebrovascular accidents. 22 The symptoms vary depending on the degree and location of vessel stenosis, although most patients exhibit symptoms of severe renovascular hypertension, absent femoral pulses, abdominal bruit, and claudication of the lower limbs. [23] [24] [25] [26] Patients with long-standing refractory hypertension may present with symptoms of hypertensive encephalopathy and retinopathy. 4, 27, 28 Current management of MAS is aimed at controlling arterial blood pressure (BP), preventing long-term complications related to hypertension, and preserving end-organ function (including heart and kidneys). Treatment can be pharmacological, endovascular, or surgical. Although pharmacological management with oral antihypertensives may be satisfactory in some cases (those with mild to moderate aortic and/or renal stenosis), 29, 30 treatment often involves surgical or endovascular procedures, with the severity of hypertension and/ or kidney impairment being the most common triggers for intervention. 25, [31] [32] [33] Several surgical interventions have been described for this condition, including aortoaortic bypass grafting, graft vascular replacement, patch angioplasty, and renal auto transplantation. 25, [33] [34] [35] [36] Endovascular procedures such as percutaneous transluminal angioplasty with or without stenting have also been performed for the management of MAS with varying success. 25, [36] [37] [38] [39] [40] The longevity of response to these procedures is always concerning, particularly in children who may develop restenosis due to differential growth and luminal discrepancies between normal and grafted, stented or balloon-dilated vessels.
MAS has been diagnosed and reported more frequently in recent years, likely due to heightened awareness from clinicians and improved noninvasive diagnostic imaging technologies such as ultrasound, multiplanar computed tomography, and magnetic resonance imaging. 3, 23, 34, 41 Still, there is a paucity of information regarding the pathogenesis of MAS, clinical spectrum of the disorder, and appropriate timing of endovascular or surgical intervention. 25 In this systematic review, we offer a literature-based description of the etiologies and clinical features of MAS in children, outline the vascular involvement of the aorta and visceral branches, and provide an overview of the medical, endovascular, and surgical management of MAS and their clinical outcomes.
METHODS

Search strategy and selection criteria
We developed a protocol for the systematic review using PRISMA guidelines, 42 to address the following questions: (i) What are the etiology, characteristics, and clinical presentation of MAS in children; (ii) what is the extent of aortic, renal, and mesenteric involvement and the morphology of the diseased vessels; and (iii) what is the management of MAS, its effectiveness and clinical outcomes, and duration of follow-up reported for these cases? We conducted searches using the Ovid interface in MEDLINE (including the "In-process & Other Non-Indexed Citations" segment), Embase, and Cochrane Central Register of Controlled Trials in April 2014, from inception of the databases. Databasespecific subject headings (e.g., MeSH in MEDLINE, Emtree in EMBASE) were selected for the concept of "middle aortic syndrome. " Database subject headings were exploded, when applicable, to include narrower terms. Numerous text word searches were generated to capture synonymous phrases and terminology. All synonymous terms and phrases were combined first using the Boolean "OR. " The concept of children aged 0-18 was searched using either database "Limits" (MEDLINE) or subject headings (Embase). In all 3 databases, the relevant ages were also searched as text words. The concepts of "middle aortic syndrome" and "children" were then combined with the Boolean "AND. " In all databases, both adjacency operators and truncation symbols were used in text word searches when appropriate, to capture variant endings of the search terms, and variant spellings and phrases. No language or date restrictions were applied to ensure maximum yield of relevant papers. The complete search strategies for each database are outlined in Supplementary Appendix I.
Data extraction and analysis
The papers were screened, and the relevant data were extracted and double-checked by a second reviewer for consistency. Any disagreements relating to eligibility or data were resolved by discussion and consensus. Data extracted from papers included patient characteristics, clinical phenotype, vessel involvement, investigations and interventions, outcomes, and follow-up. The analysis consisted of descriptive statistics of demographic and clinical characteristics, distribution of vascular involvement, and management and outcomes of the reported cases.
Etiology was classified as idiopathic, genetic, inflammatory, or fibromuscular dysplasia (FMD). Etiology was idiopathic if no specific underlying diagnosis was made, or if the etiology was assumed to be congenital due to presentation during infancy. Etiology was defined as genetic if the patient had any of the following known Mendelian disorders: Neurofibromatosis type I, Williams' syndrome, or Alagille's syndrome. An inflammatory etiology was designated if the patient had an inflammatory disease such as Takayasu's arteritis or nonspecific large vessel arteritis, and/ or was treated for an inflammatory condition. The etiology of FMD was designated to case reports whose authors employed this diagnosis in association with coarctation of the abdominal aorta.
Anatomic involvement of the abdominal aorta was described in reference to the renal arteries (suprarenal, infrarenal, or interrenal stenosis of the abdominal aorta). Cases with long diffuse aortic stenosis were classified as a suprarenal to infrarenal involvement. Involvement of the thoracic aorta was defined as stenosis of the descending aorta above the diaphragm. Information regarding the location (ostial or distal) and morphology (segmental or diffuse) of the stenotic vessel was collected if provided.
If no mention of symptoms, clinical findings, or endorgan damage were reported, the information was assumed to be missing. Outcomes of medical management of hypertension with oral antihypertensives were classified as: BP control (normotensive with antihypertensive therapy), BP improvement (BP improved but remained elevated and still necessitated antihypertensive therapy), and treatment non response (no reduction in BP with drug therapy). Outcomes of surgical and endovascular intervention were classified as: uneventful (successful intervention), complicated (aortic tear, bleeding, thrombosis, aneurysm, stent embolization), procedure failure (a technically failed procedure such as recoil of the vessel, or reintervention), or death.
Anatomic involvement, extent of vessel stenosis, and clinical presentation were reported variably, but qualitative data were captured where available. Missing information was described as such to highlight any inconsistency in the reporting of cases in the literature. Data were analyzed with STATA, version 11. Categorical data are reported as proportions, and continuous data are presented as the mean ± SD or median (interquartile range), as appropriate.
RESULTS
Study selection
The search identified a total of 1,252 potentially relevant articles, of which 401 were duplicates ( Figure 1 ). The remaining 851 citations identified were independently screened through title and abstract, and 587 papers were selected for full review if they met predefined inclusion criteria outlined in Table 1 . A total of 184 studies of 630 cases, published between 1953 and 2014, were included in this review. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [19] [20] [21] [22] [23] [24] [25] [26] 28, 29, [31] [32] [33] [34] [35] [37] [38] [39] [40] The characteristics of the papers selected for inclusion in this review are summarized in Supplementary Table 1 . Almost all studies are case reports or case series and none are longitudinal cohort studies by design, hence, there is significant variability in the quality of the data presented and little consistency in the reporting of data. Based on the design of the studies, a validated risk of bias assessment tool could not be used to evaluate the quality of each paper.
Patient characteristics
A total of 630 children reported in 184 publications are included in this review. Table 2 summarizes their clinical characteristics. The mean age of the children at presentation is 9.1 (SD ± 5) years, and 45% of children are male. The most common finding at presentation is hypertension (87%). The vast majority of reports do not describe symptoms, clinical findings at presentation, or indices of end-organ damage. There is very little data available to describe the clinical phenotype of MAS in children.
Etiology and associated diagnoses
Most cases of MAS are idiopathic (64%). Associated known Mendelian and inflammatory diseases are found in 15% and 17% of reported cases, respectively. A diagnosis of FMD is made in approximately 4% of cases, although histopathological or angiographic data to support the diagnosis are not reported. 
Aortic vessel disease
Involvement of the aorta, visceral branches, and other vessels is summarized in Table 3 . Narrowing of the abdominal aorta is reported in 97% of cases, while the distal thoracic aorta is involved in 3% of cases. The most common anatomic site within the abdominal aorta is suprarenal (29%), followed by suprarenal to infrarenal stenosis (12%), and infrarenal involvement (8%). Morphology of the vessel is not reported in 62% of cases, but of those cases with known morphology, a discrete segmental narrowing (23%) is slightly more common than long diffuse stenosis (15%). Vascular involvement in MAS by etiology is presented in Table 4 . In terms of etiology, those with idiopathic MAS have a higher rate of infrarenal aortic stenosis compared to other etiologies, while cases with known Mendelian disorders have a higher rate of suprarenal aortic involvement. Aneurysms of the abdominal aorta are reported in 11% of cases, with the highest proportion of reports in cases with inflammatory disease.
Extra-aortic vessel involvement
Renal artery stenosis (RAS) at initial presentation is common (66%). Approximately 60% of these cases have bilateral RAS, while 20% have unilateral renal artery involvement, and the remaining cases are not clearly defined. The stenosis is restricted to the ostial region of the vessel in 35% of cases, although the remaining cases are not described in enough detail. Morphology of the renal vessels is also not reported in 87% of the cases; of those reported, a segmental narrowing of the renal artery is more commonly seen than a diffuse lesion, and none describe beading pattern of vessel involvement.
The superior mesenteric artery (SMA) is affected in 30% of the cases, and the celiac trunk in 22% of cases. The inferior mesenteric artery is rarely involved. Collateral vessels are noted in 15% of patients. Only 30% of cases have abdominal aortic coarctation with no other visceral branch involvement. The remaining 70% have at least one other visceral branch involved (SMA, celiac, or renal): 38% have 1 visceral arterial stenosis, 14% have 2, and 18% have 3 arteries involved.
Retinal and cerebral vascular abnormalities are confirmed in only 10% and 3% of the cases, respectively, with the remainder lacking information. Cases associated with genetic disorders have more extensive extra-aortic involvement, including a higher incidence of RAS, as well as SMA and celiac artery involvement, while cases with arteritis appear to be more localized to the abdominal aorta. Data on carotid and subclavian vessel involvement are lacking in over 95% of the cases. The SMA and celiac vessels are not affected in FMD cases as compared to the other etiologies. Aortic and extra-aortic involvement in MAS is illustrated in Figure 2 .
Medical management
A total of 383 patients (61%) received oral antihypertensive drugs upon initial presentation, 18% did not receive antihypertensive therapy, and the remaining cases are not clearly reported. Some cases required a regimen of multiple antihypertensive drugs. The most commonly used agents include: beta-blockers (20%), angiotensin-converting enzyme inhibitors (13%), diuretics (8%), and alpha-blockers (7%). Of the cases treated conservatively, 14% became normotensive with antihypertensive medication, and 36% had an improvement in BP with drug therapy. In 44% of the cases, the hypertension was refractory to medication. Data are not reported for the remaining 6% of cases receiving medications. Outcomes associated with the medical management of MAS for each diagnosis are described in Table 6 . Overall, cases with associated with known Mendelian disorders responded better to antihypertensive medications, while idiopathic cases had the highest rate of treatment nonresponse. There is little data reported on the use of corticosteroids for management.
Endovascular and surgical intervention
Data on endovascular and surgical management of MAS are summarized in Table 5 . Approximately 28% of patients underwent an endovascular intervention, which consisted of percutaneous transluminal angioplasty with or without stenting. The postoperative course of endovascular treatment was uneventful in half of the cases. Approximately 13% of patients had complications related to the endovascular procedure. Failure of endovascular procedures is reported in 28% of the cases: this consisted of technical failure or need for reintervention. Mortality attributable to endovascular intervention was 2.3%. Outcomes are not reported in the remaining 6% of cases.
Surgical treatment was performed in 348 of the reported cases (55%) and included aortoaortic bypass as the treatment of choice in 42% of patients, reconstruction patch graft in 23%, and renal autotransplantation in 11% of cases. Of those receiving surgical intervention, 25 patients (7%) had concomitant endovascular procedures, and 41 cases (12%) had surgery following a failed endovascular intervention. The postoperative course following surgical intervention was uneventful in the majority of cases (65%), complicated in 9% of cases, and technical failure is reported in 8% of cases. Death attributable to surgical treatment was 2.9%. Surgical outcomes are not reported in the remaining 14% of cases. Outcomes of endovascular and surgical interventions by etiology are outlined in Table 6 . Cases with associated arteritis had the highest rate of complications during surgical interventions.
Follow-up and BP control
Follow-up data are reported for 68% of cases, median follow-up is 4 years (interquartile range: 1-5 years). In terms of BP control, 119 cases (18.9%) were normotensive without any antihypertensive medications, 167 cases (26.5%) were normotensive but receiving antihypertensive therapy, 48 cases (7.6%) had uncontrolled BP, and 121 cases (19.2%) were reported to have adequate BP control but with no mention of presence or absence of drug therapy. Total 30-day mortality was 2.7%, and the total number of deaths reported was 33 (5.2%). No follow-up data was provided for the remaining 142 (22.6%) of cases. Table 7 summarizes reported outcomes following surgical and endovascular interventions. A total of 136 cases (22%) needed reintervention, and 47 cases (7.5%) had a complete or partial nephrectomy. On follow-up, restenosis of the stenotic segment was reported in 34 cases (5.4%); 9 of these cases were after surgery, 13 were after endovascular intervention, and 12 were after receiving both interventions. 
DISCUSSION
MAS is a complex clinical entity in childhood that has been recognized more frequently in the last decade. Based on our review, we found that children often present at an older age with the initial finding of hypertension, and the vast majority of MAS cases in childhood are idiopathic. Involvement of the aorta is also relatively consistent, and confined to the perirenal segment of the abdominal aorta, with many having ostial stenosis of the renal arteries and visceral branches. An interesting feature is the complete lack of inferior mesenteric artery involvement. Many patients undergo surgical and endovascular interventions to better manage the hypertension; however, with varying success, and often have residual hypertension despite intervention.
The location and length of the aortic narrowing in patients with MAS is highly variable. The stenosis can be a short focal constriction restricted to a few millimeters along the length of the aorta, 34 or it can be a long diffuse narrowing extending from above the renal arteries to a point above the inferior mesenteric artery. 6, 66 The abdominal aortic involvement may be classified anatomically using the most proximal site of obstruction of the aorta: suprarenal, interrenal, or infrarenal and can also include renal, celiac, and mesenteric vessels. 27, 28, 36, 82 The most common lesion is suprarenal, although this varies by etiology of disease. This review illustrates the high prevalence of renal artery involvement, with 70% of cases having RAS at the time of initial presentation. RAS is more prevalent in patients with MAS than previously reported and may complicate management. Although the morphology and anatomy of the renal vessels are not adequately described across all reports, the stenosis is often restricted to the ostial region of the renal arteries, with a high propensity for bilateral stenosis of the renal vessels. 3, 31, 33, 34 Moreover, the perirenal segment of the aorta is almost always involved and could indicate specific developmental patterning required for normal formation. The SMA and celiac trunk are involved in 30% and 20% of cases, respectively. The inferior mesenteric artery is almost never involved in MAS, which along with the observation that disease is confined to the perirenal segment of the abdominal aorta, suggests that MAS may be an aberrant developmental anomaly. Data on the extent of carotid, cerebral, and retinal vascular involvement are lacking, thus it is not known if MAS is a systemic disorder.
The etiology of MAS remains largely unknown, and the majority of cases are idiopathic. This is partly due to the fact that pathological studies have rarely been carried out in the reported cases. In the few cases where specimens are studied, there is either normal histology or pathological features are nonspecific and indistinguishable across potential etiologies. 2, 38, 191 Cases described in association with recognized Mendelian disorders, namely Williams' syndrome, Alagille's syndrome, and neurofibromatosis type I, have more extensive vessel disease, including involvement of the renal and mesenteric arteries, as compared to idiopathic MAS. This may suggest a common genetic pathway that could explain the overlap in the location and morphology of the lesion. It is worth mentioning that cases of MAS caused by FMD are mostly earlier reports made with no clear supporting evidence from radiological studies or pathology. The string of beads pattern characteristic of FMD is not commonly seen in children, and the diagnosis of FMD is assumed in most cases. 35, 192, 193 Furthermore, the lesion in FMD is confined to the middle or distal portion of the vessel in the majority of cases, 191, 194 which is contrary to the lesions present in MAS patients. Stenosis of the renal and visceral vessels in MAS almost exclusively involves the origin of the vessel and rarely extends beyond a few millimeters of the origin. 8, 78 Therefore, it is likely that MAS in children represents a separate clinical entity not consistent with FMD. Surgical or endovascular intervention is often offered to lower BP and alleviate symptoms, although indications for invasive management of MAS are not defined. 28, 31 Location of the stenosis, length of the segment, and extent of visceral vessel involvement are all factors to consider. 25, 28, 35 Management is therefore multidisciplinary, requiring an individualized approach depending on the severity of clinical presentation, response to medical therapy, and extent of end-organ damage. 3, 58, 74, 82, 192 Our data suggest that despite improved knowledge and surgical technique over the past few decades, endovascular and surgical interventions are associated with complications including aortic rupture or dissection, bleeding, thrombosis, stenosis of the graft, and iatrogenic tears. 5, 11, 25, 54 Although endovascular and surgical management may be acutely successful in relieving aortic obstructions, 28 freedom from reintervention may not necessarily be achieved. Additionally, residual hypertension is common and requires use of antihypertensive medication or a secondary intervention. Inadequate BP control following intervention is reported in over one third of patients, which, according to some reports, is a poor prognostic factor that impacts event-free survival. 27, 195 Lastly, the longevity of any therapeutic response is difficult to ascertain, yet a concerning issue. As children and adolescents grow, restenosis and impaired flow may develop due to fibrosis related to instrumentation or the obvious lack of growth expected from grafts or stents. Considering life expectancy in this patient population, duration of monitoring and medium or long-term improvement remains a critical yet largely unknown aspect of care.
There are several limitations to this review, in which data were dependent on the quality of the studies, with a substantial amount of missing information. The clinical phenotype and extent of end-organ damage have not been adequately reported in the literature, which could be due to incomplete investigations carried out or to a lack of systematic reporting of cases. Addressing this paucity of information through detailed clinical phenotyping of MAS will provide insight into the extent of the disease, and thus impact decision-making. Long-term follow-up is not adequately reported, and data on growth, intestinal ischemia, and food intolerance are lacking. Additionally, there are inconsistencies in the reporting and terminology used to describe vascular lesions. Reporting bias is likely present where more severe forms of disease or surgical cases are reported more frequently. Despite the limitations, this review provides a summary of the reported cases of MAS in terms of patient characteristics, vascular involvement, and management, while highlighting the gaps in knowledge. There are currently no studies on MAS that explore potential risk factors, exposures, and demographic, social, or psychosocial factors. Knowledge of the natural history of MAS is limited to early reports which describe poor prognosis in patients treated conservativ ely. 26, 31, 33, 76, 131, 158 Further work is needed to understand etiology of the disease, delineate disease progression and vascular phenotype, and ultimately impact clinical management. Additional consideration of more advanced vascular imaging will lead to a better understanding of the extent of disease and may point to possible undiagnosed etiologies.
CONCLUSION
Patients with MAS often have additional visceral stenosis and most commonly RAS. The extent of vascular disease may also differ based on genetic or inflammatory conditions. The pathogenesis of MAS and optimal interventions have yet to be elucidated. Persistent hypertension after intervention is a common feature that requires further evaluation and longterm monitoring of children.
SUPPLEMENTARY DATA
Supplementary materials are available at American Journal of Hypertension (http://ajh.oxfordjournals.org).
